SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001023024-24-000059
Filing Date
2024-05-14
Accepted
2024-05-14 16:11:27
Documents
22
Period of Report
2024-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ani-20240514.htm   iXBRL 8-K 29883
2 EX-99.1 exhibit991investordeckma.htm EX-99.1 15652
6 exhibit991investordeckma001.jpg GRAPHIC 64612
7 exhibit991investordeckma002.jpg GRAPHIC 320201
8 exhibit991investordeckma003.jpg GRAPHIC 125597
9 exhibit991investordeckma004.jpg GRAPHIC 108556
10 exhibit991investordeckma005.jpg GRAPHIC 127412
11 exhibit991investordeckma006.jpg GRAPHIC 159617
12 exhibit991investordeckma007.jpg GRAPHIC 115514
13 exhibit991investordeckma008.jpg GRAPHIC 64625
  Complete submission text file 0001023024-24-000059.txt   1671957

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ani-20240514.xsd EX-101.SCH 1874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ani-20240514_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ani-20240514_pre.xml EX-101.PRE 12491
25 EXTRACTED XBRL INSTANCE DOCUMENT ani-20240514_htm.xml XML 2690
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 24944454
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)